(Q35546045)

8 August 2017

title

Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013 (English)

1 reference

8 August 2017

0 references

0 references

1 reference

17

François Bricaire

0 references

Papa Alioune Ndour

3

Papa Alioune Ndour

1 reference

8 August 2017

Stéphane Jauréguiberry

1

Stéphane Jauréguiberry

1 reference

8 August 2017

20

Eric Caumes

0 references

Benjamin Wyplosz

Benjamin Wyplosz

10

0 references

Marc Thellier

Marc Thellier

2

0 references

Romain Sonneville

Romain Sonneville

6

0 references

Pierre Buffet

Pierre Buffet

19

0 references

Sophie Matheron

Sophie Matheron

8

0 references

Eric Kendjo

14

Eric Kendjo

1 reference

8 August 2017

16

Sandrine Houzé

1 reference

8 August 2017

18

Dominique Mazier

1 reference

8 August 2017

Flavie Ader

4

1 reference

8 August 2017

Camille Roussel

5

1 reference

8 August 2017

Julien Mayaux

7

1 reference

8 August 2017

Adela Angoulvant

9

1 reference

8 August 2017

Christophe Rapp

11

1 reference

8 August 2017

Thierry Pistone

12

1 reference

8 August 2017

Bénédicte Lebrun-Vignes

13

1 reference

8 August 2017

Martin Danis

15

1 reference

8 August 2017

Eric Caumes

20

1 reference

8 August 2017

French Artesunate Working Group

21

1 reference

8 August 2017

language of work or name

1 reference

1 May 2015

1 reference

Emerging Infectious Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

21

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

804-812

1 reference

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Artesunate versus quinine for treating severe malaria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Severe imported Plasmodium falciparum malaria, France, 1996-2003.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Intravenous artesunate for severe malaria in travelers, Europe

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

For severe malaria, artesunate is the answer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Severe imported falciparum malaria: a cohort study in 400 critically ill adults

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Intravenous artesunate for the treatment of severe malaria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Recommendations for clinical practice. Management and prevention of imported Plasmodium falciparum malaria. (Revision 2007 of the 1999 Consensus conference). Short text

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Artesunate for the treatment of severe falciparum malaria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Ex vivo perfusion of human spleens maintains clearing and processing functions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria--worldwide, 2010-2012.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Severe malaria, artesunate and haemolysis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Severe malaria and artesunate treatment, Norway

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Severe falciparum malaria with prolonged hemolytic anemia after successful treatment with intravenous artesunate

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

Artemisinin-based combination therapies and their introduction in Japan

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4412216

26 September 2018

Identifiers

DOI

10.3201/EID2105.141171

1 reference

8 August 2017

1 reference

8 August 2017

1 reference